News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Artimplant Invests in Expanded Own Sales


1/3/2012 6:28:11 AM

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--With effect from January 1, 2012, Artimplant will take over responsibility for sales of Artelon® CMC Spacer, previously handled by the licensee SBi. This is an integral part of Artimplant's focus on reinforcing its presence on the very important US market.

Since December 2011, Artimplant has had a stronger sales organization in place in the USA, which it is felt will contribute positively to the company's presence and sales volumes. By assuming responsibility for sales of Artelon® CMC Spacer and other products for restoring joint surfaces, Artimplant will have a more complete product offering on the US market. Artelon® CMC Spacer is considered to have major market potential, which Artimplant is in a better position to develop by assuming direct control of sales.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES